Yuekang Pharmaceutical/ CNE100005XQ2 /
2024-06-11 9:00:00 AM | Chg. -0.06 | Volume | Bid2024-06-11 | Ask9:00:03 AM | High | Low |
---|---|---|---|---|---|---|
17.49CNY | -0.34% | 2.15 mill. Turnover: 37.3 mill. |
17.49Bid Size: 7,064 | 17.53Ask Size: 500 | 17.58 | 17.04 |
GlobeNewswire
8:05 PM
OKX CMO Haider Rafique and BBDO Worldwide CEO Andrew Robertson Explore the Future of Marketing at Tr...
GlobeNewswire
7:24 PM
Norton Rose Fulbright enhances global investigations practice with 12-lawyer team
GlobeNewswire
7:23 PM
Brandon Hall Group Launches Comprehensive Study on the State of Corporate Learning & Development
GlobeNewswire
7:22 PM
Collaborating with Workers to Combat 2,000 Daily Eye Injuries: Ergodyne Leads the Way
GlobeNewswire
7:15 PM
VS Media Holdings Limited Announces Delay in Effective Date of Reverse Split to June 18, 2024
GlobeNewswire
7:11 PM
F&M Bank Employees Team up with Habitat for Humanity to Build Playhouses for Deserving, Northwest Oh...
GlobeNewswire
7:00 PM
Exploring the LSP Protocol: The Best Solution for Building a Security Moat for PoS Networks
GlobeNewswire
6:53 PM
Malibu Boats, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Fir...
GlobeNewswire
6:47 PM
New Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, ...
GlobeNewswire
6:46 PM
SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emuls...